共 19 条
[6]
Monitoring of peripheral blood CD34+cell counts on the first day of apheresis is highly predictive for efficient CD34+cell yield
[J].
THERAPEUTIC APHERESIS,
2002, 6 (05)
:384-389
[7]
Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2009, 27 (28)
:4767-4773